Drug association of one or more nucleic acids inhibiting at least partially the oncogenic cell signaling pathways and an anti-cancer therapeutic agent and drug association of one or more tumor suppressor genes and a taxoid

摘要

A medicinal combination of one or more nucleic acids that at least partially inhibit oncogenic cell signalling pathways, and a therapeutic anticancer agent, for use simultaneous, separate or over a period of time to treat hyperproliferative diseases.